| Secondary |
| Product Used For Unknown Indication |
37.4% |
| Hypertension |
11.5% |
| Blood Electrolytes Abnormal |
5.8% |
| Pain |
5.8% |
| Acute Lymphocytic Leukaemia Recurrent |
4.3% |
| Menstrual Disorder |
4.3% |
| Atrial Fibrillation |
3.6% |
| Bartter's Syndrome |
2.9% |
| Blood Calcium Decreased |
2.9% |
| Hypokalaemia |
2.9% |
| Myocardial Ischaemia |
2.9% |
| Nausea |
2.9% |
| Prophylaxis |
2.9% |
| Antiemetic Supportive Care |
1.4% |
| Blood Magnesium Decreased |
1.4% |
| Blood Phosphorus Decreased |
1.4% |
| Blood Potassium Decreased |
1.4% |
| Dyspepsia |
1.4% |
| Flushing |
1.4% |
| Haemorrhage |
1.4% |
|
| Renal Failure Acute |
26.7% |
| Nodal Arrhythmia |
13.3% |
| Off Label Use |
13.3% |
| Stomatitis |
13.3% |
| Death |
6.7% |
| Medication Error |
6.7% |
| Rash |
6.7% |
| Rash Erythematous |
6.7% |
| Restlessness |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
47.0% |
| Drug Use For Unknown Indication |
10.8% |
| Prophylaxis |
6.2% |
| Adverse Event |
4.6% |
| Hypertension |
3.9% |
| Atrial Fibrillation |
3.3% |
| Pain |
2.9% |
| Pulmonary Arterial Hypertension |
2.5% |
| Plasma Cell Myeloma |
2.5% |
| Nausea |
2.0% |
| Aplastic Anaemia |
1.8% |
| Constipation |
1.8% |
| Chemotherapy |
1.6% |
| Supplementation Therapy |
1.5% |
| Cardiac Failure |
1.5% |
| Diabetes Mellitus |
1.5% |
| Pneumonia |
1.5% |
| Hypokalaemia |
1.3% |
| Insomnia |
1.2% |
| Fluid Replacement |
1.1% |
|
| Vomiting |
16.5% |
| Oedema Peripheral |
6.8% |
| Upper Gastrointestinal Haemorrhage |
5.3% |
| Weight Decreased |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Death |
4.5% |
| Diarrhoea |
4.5% |
| International Normalised Ratio Increased |
4.5% |
| Pulmonary Embolism |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Renal Failure Acute |
4.5% |
| Thrombocytopenia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Weight Increased |
4.5% |
| Pain In Extremity |
3.8% |
| Sepsis |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Hypertension |
3.0% |
| Paraesthesia |
3.0% |
| Plasma Cell Myeloma |
3.0% |
|
| Interacting |
| Diabetes Mellitus |
50.0% |
| Circadian Rhythm Sleep Disorder |
25.0% |
| Supplementation Therapy |
25.0% |
|
| Withdrawal Arrhythmia |
100.0% |
|
